Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 33418 | 92 | 37.2 | 93% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | PBK TOPK | Author keyword | 26 | 100% | 12% | 11 |
| 2 | PDZ BINDING KINASE | Author keyword | 14 | 100% | 8% | 7 |
| 3 | PBK | Author keyword | 4 | 56% | 5% | 5 |
| 4 | BREAST ENDOCRINE SURGMIYAMAE KU | Address | 2 | 67% | 2% | 2 |
| 5 | TOP K | Author keyword | 2 | 12% | 14% | 13 |
| 6 | TOPK PBK | Author keyword | 1 | 100% | 2% | 2 |
| 7 | LASER MICROBEAM MICRODISSECTION | Author keyword | 1 | 33% | 2% | 2 |
| 8 | BIOTECHNOL COMPUTAT BIOL | Address | 1 | 50% | 1% | 1 |
| 9 | CINI | Author keyword | 1 | 50% | 1% | 1 |
| 10 | MED INFORMATMINATO KU | Address | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | PBK TOPK | 26 | 100% | 12% | 11 | Search PBK+TOPK | Search PBK+TOPK |
| 2 | PDZ BINDING KINASE | 14 | 100% | 8% | 7 | Search PDZ+BINDING+KINASE | Search PDZ+BINDING+KINASE |
| 3 | PBK | 4 | 56% | 5% | 5 | Search PBK | Search PBK |
| 4 | TOP K | 2 | 12% | 14% | 13 | Search TOP+K | Search TOP+K |
| 5 | TOPK PBK | 1 | 100% | 2% | 2 | Search TOPK+PBK | Search TOPK+PBK |
| 6 | LASER MICROBEAM MICRODISSECTION | 1 | 33% | 2% | 2 | Search LASER+MICROBEAM+MICRODISSECTION | Search LASER+MICROBEAM+MICRODISSECTION |
| 7 | CINI | 1 | 50% | 1% | 1 | Search CINI | Search CINI |
| 8 | RQCD1 | 1 | 50% | 1% | 1 | Search RQCD1 | Search RQCD1 |
| 9 | T LAK CELL ORIGINATED PROTEIN KINASE TOPK | 1 | 50% | 1% | 1 | Search T+LAK+CELL+ORIGINATED+PROTEIN+KINASE+TOPK | Search T+LAK+CELL+ORIGINATED+PROTEIN+KINASE+TOPK |
| 10 | AKT SIGNAL | 0 | 33% | 1% | 1 | Search AKT+SIGNAL | Search AKT+SIGNAL |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PDZ BINDING KINASE | 53 | 89% | 26% | 24 |
| 2 | ORIGINATED PROTEIN KINASE | 29 | 77% | 22% | 20 |
| 3 | MITOTIC KINASE | 15 | 38% | 34% | 31 |
| 4 | RPMI7951 MELANOMA CELLS | 8 | 100% | 5% | 5 |
| 5 | TOPK PHOSPHORYLATION | 8 | 100% | 5% | 5 |
| 6 | TOP K | 7 | 64% | 8% | 7 |
| 7 | PBK TOPK | 6 | 71% | 5% | 5 |
| 8 | SYNOVIAL SARCOMAS | 3 | 26% | 10% | 9 |
| 9 | ONCOGENIC ROLE | 2 | 43% | 3% | 3 |
| 10 | ERYTHROID P55 | 1 | 50% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Mechanisms of action of DNA-damaging anticancer drugs in treatment of carcinomas: Is acute apoptosis an "off-target" effect? | 2007 | 44 | 65 | 3% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BREAST ENDOCRINE SURGMIYAMAE KU | 2 | 67% | 2.2% | 2 |
| 2 | BIOTECHNOL COMPUTAT BIOL | 1 | 50% | 1.1% | 1 |
| 3 | MED INFORMATMINATO KU | 1 | 50% | 1.1% | 1 |
| 4 | HOSP MED SCI | 0 | 33% | 1.1% | 1 |
| 5 | KONYANG HOSP | 0 | 25% | 1.1% | 1 |
| 6 | HIGH THROUGHPUT TECHNOL | 0 | 13% | 2.2% | 2 |
| 7 | BIOREGULAT MED | 0 | 20% | 1.1% | 1 |
| 8 | NEURAL DEV OPT RECORDING NDEVOR | 0 | 17% | 1.1% | 1 |
| 9 | COLORECTAL CANC CLIN | 0 | 14% | 1.1% | 1 |
| 10 | DIGEST TRANSPLANTAT SURG | 0 | 14% | 1.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000223411 | MELK//MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE//MAK V HUNK PROTEIN KINASE |
| 2 | 0.0000145637 | CANC VACCINE DEV//INNOVAT CANC THER Y//PERSONALIZED PEPTIDE VACCINE |
| 3 | 0.0000087540 | PROHIBITIN//PROHIBITIN 1//BRE |
| 4 | 0.0000075890 | MAGUK//PDZ DOMAIN//PSD 95 SAP90 |
| 5 | 0.0000064838 | PANDER//FAM3B//PANCREATIC DERIVED FACTOR |
| 6 | 0.0000064231 | CYTOKINESIS//CLEAVAGE FURROW//CENTRALSPINDLIN |
| 7 | 0.0000063199 | CHFR//EPIGENETCANC//P41 ARC |
| 8 | 0.0000062348 | STE20 LIKE KINASE//MAP4K4//STE20 |
| 9 | 0.0000060995 | CDCP1//TRASK//SUBTRACTIVE IMMUNIZATION |
| 10 | 0.0000058554 | FLIGHTLESS I//TTYH1//TWEETY |